Form 4: Labcorp SVP Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Labcorp's SVP, Chief Accounting Officer, Peter J. Wilkinson, sold 666 shares of common stock for $277.94 per share under a pre-arranged 10b5-1 plan.

Summary

  • Peter J. Wilkinson, SVP, Chief Accounting Officer of Labcorp Holdings Inc. (LH), reported a transaction.
  • The transaction involved the sale of 666 shares of Common Stock.
  • The shares were sold at a price of $277.94 per share.
  • The transaction occurred on February 19, 2026.
  • The sale was executed pursuant to a Rule 10b5-1 plan under the Securities Exchange Act of 1934.
  • Following this transaction, Peter J. Wilkinson directly beneficially owns 1,852.2194 shares of Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. Insider sales under a pre-arranged 10b5-1 plan are routine and do not typically convey new information about the company's performance or future prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider sales executed under Rule 10b5-1 plans are common and typically pre-scheduled, often for personal financial planning purposes. Such transactions generally do not reflect a change in management's outlook on the company's prospects, as the decision to sell was made at an earlier date when the plan was established.

Stakeholder Impact

  • Shareholders: Minimal impact, as this is a routine, pre-scheduled insider transaction that does not typically signal new material information about the company's fundamentals.

Key Dates

DateDescription
02/19/2026Date of earliest transaction (sale of common stock)
02/23/2026Date the Form 4 was signed by Kathryn W. Kyle, Attorney-in-Fact for Peter J. Wilkinson

Recommendation

hold

The sale of shares by an executive under a pre-arranged 10b5-1 plan is a routine event and does not typically signal a change in the company's fundamental outlook or warrant a shift in investment recommendation. Investors should continue to evaluate Labcorp based on its financial performance and strategic initiatives.

Keywords

Labcorp Holdings Inc., LH, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Peter J. Wilkinson, Chief Accounting Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.